Julia Bonavitacola

The meeting covered several topics in eye care, including how artificial intelligence (AI) can play a part in eye care.

Those using e-cigarettes were more likely to develop cataracts, and those receiving cataract surgery less likely to develop depression and anxiety.

The conference session featured updates on several clinical trials, including the BRUNELLO trial, for treatment of diabetic macular edema (DME).

Panelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.

A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.

The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in health care.

Incidence of diabetic macular edema and the need for glaucoma surgery were reduced after treatment with glucagon-like peptide-1 receptor agonists.

The conference, held in New Orleans, Louisiana, by the American Academy of Ophthalmology, will offer 3 full days of content spanning from glaucoma to dry eye.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Dry eye disease primarily causes stinging in the eye and blurry vision, which can affect quality of life.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Veligrotug is a newly FDA-approved treatment that can target the proptosis associated with thyroid eye disease.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

There was no observed increase in risk to short- or mid-term clinically relevant infections despite the low levels of immunoglobulins.

Veligrotug-vvze (Lumvoa; Viridian Therapeutics) is the first treatment for thyroid eye disease (TED) that has been approved by the FDA with labeling that includes data for both active and chronic TED.

Lower rates of successful discharge were reported in home health care patients whose care was interrupted by flooding related to hurricanes.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Spending on health expenditures will make up 20.6% of gross domestic product, according to a federal report.

Interviews with patients living with generalized myasthenia gravis (MG) in the US revealed areas of increased burden in these patients.

Patients with early relapsing multiple sclerosis (MS) were able to switch to ocrelizumab after suboptimal responses to other disease-modifying therapies.

The 2026 conference, held in Baltimore, Maryland, offered expert insight into the past and future of sleep medicine.

More short-term injections were needed to maintain visual outcomes in patients who lost their co-payment assistance.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A meta-analysis evaluated the efficacy of various monoclonal antibodies in treating patients with myasthenia gravis (MG).

Mobile health models that include artificial intelligence and smartphone imaging can help address gaps in early detection.

Changes in PrEP for HIV expand choice and reduce risk as new research continues to look for an elusive cure.

Patients with narcolepsy type 1 reported high disease burden, including chronic symptoms like hallucinations, sleep paralysis, and difficulty concentrating.

Late-breaking abstracts presented during the Sleep 2026 Annual Meeting provided new data on how the time of year could change sleep duration and the efficacy of low-sodium oxybate.